Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor
Against the Odds: Urban Company's Surprising Comeback Amidst Market Whirlwinds
Unpacking BKV's Q3: The Story Behind the Numbers
The Green Haze Lingers: Cronos Group's Q3 Report Reveals a Winding Path Ahead
The Urban Company Balancing Act: Growth, Losses, and the Quest for Profitability
Amarin's Tumultuous Tides: A Deep Dive into Q3's Financial Currents
The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance
Turbulence Ahead: SpiceJet's Lingering Salary Delays Spark Employee Distress and Financial Scrutiny
GLCL's Q1 FY2025 Sales Plummet 56%, Company Swings to Net Loss
S Chand & Co Faces Significant Headwinds: Sales Plummet by 20% While Net Profit Dips into Loss in Q1 FY2026
Cathay Cineplexes Owner mm2 Asia Plunges into Deeper Loss Amidst Massive Impairment
Vivos Therapeutics Navigates Headwinds: A Closer Look at Q2 2025 Performance and Future Outlook
Asian Hotels Navigates Mixed Fortunes: Sales Soar, Net Loss Widens in Q1 FY26
Bit Mining's Shares Plummet: Deeper-Than-Expected Loss Rocks Investor Confidence
Tuhura Biosciences Shines in Q2 2025: Strong Financials and Promising Pipeline Advancements Unveiled